Research
Retinal research is one of the pivotal strengths of the Mass Eye and Ear Ophthalmology Department. We maintain several research efforts in the sciences of retinal function and associated diseases. Please see the website sections of these laboratory efforts for more information. (links)
Clinical Trials relating to Age-Related Macular Degeneration
Actively recruiting participants
Comparison of AMD Treatments Trials (CATT)
This multi-center randomized clinical trial is designed to investigate the efficacy of ranibizumab (Lucentis™) vs. bevacizumab (Avastin™) for wet age-related macular degeneration. This study will also compare monthly vs. “as-needed” treatment regimens. Patients with newly diagnosed, untreated wet AMD are eligible for enrollment.
Ongoing, recruitment closed
Age-Related Eye Disease Study 2 (AREDS2)
The AREDS 2 study is examining the effect of oral supplementation of lutein/xeathanthin and/or long chain omega-3 fatty acids on progression to advanced age-related macular degeneration. An additional goal of the study is to assess whether forms of the AREDS nutritional supplement with reduced zinc and/or no beta-carotene are as effective as the original formula in reducing the risk of progression to advanced AMD.
Contact
Call (617) 573-3288 to inquire or make an appointment.
Related Information
Feedback
We want your feedback!
Do you have questions or comments? We ask you to take a few minutes to share with us your impressions of this website, your need for additional information about the Mass. Eye and Ear, or any other comments that you may have, including your suggestions on how we might better serve the community through our community benefits program. If you would like a response, please include your contact information.
Did you find this page helpful?
